Dr. Luchs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 N Flagler Dr
Ste 104
West Palm Beach, FL 33401Phone+1 561-659-9700Fax+1 561-659-9700
Summary
- Dr. Jodi Luchs is an ophthalmologist based in West Palm Beach, FL, specializing in Cataract and Refractive Surgery, and Cornea/External Disease. He completed his medical education at Albert Einstein College of Medicine in 1991, followed by an internship in Internal Medicine at Icahn School of Medicine at Mount Sinai Medical Center in NYC, and Residency in Ophthalmology at Long Island Jewish Medical Center. Dr. Luchs also completed a fellowship in Cornea and External Disease at Wills Eye Hospital. He is the Director of Cornea/External Disease at Florida Vision Institute and serves as Chief Science Advisor at InFocus Capital Partners. He is also The Chief Medical Officer at Stuart Therapeutics. He has held a faculty position at Zucker School of Medicine at Hofstra/Northwell since 2012. Dr. Luchs has published extensively on topics such as dry eye disease and keratoconus, and has been involved in numerous clinical trials. His work has earned him an Achievement Award and a fellowship from the American Academy of Ophthalmology.
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalFellowship, Cornea, External Diseases, and Refractive Surgery, 1995 - 1996
- Zucker School of Medicine at Hofstra/NorthwellResidency, Ophthalmology, 1992 - 1995
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Internal Medicine, 1991 - 1992
- Albert Einstein College of MedicineClass of 1991
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Wills Eye Hospital
Certifications & Licensure
- NY State Medical License 1992 - 2026
- FL State Medical License 2018 - 2025
- PA State Medical License 1995 - 1996
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Achievement Award American Academy of Ophthalmology, 2017
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Safety and Efficacy of Optive in Contact Lens Wearers With Dry Eyes Start of enrollment: 2007 May 01
- A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis Start of enrollment: 2009 Jun 01
- Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas Start of enrollment: 2010 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial.Barry A Schechter, Maitee Urbieta, Jason Bacharach, Melissa Toyos, Robert Smyth-Medina
Clinical Ophthalmology. 2022-01-01 - 4 citationsPhase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca.John D. Sheppard, M.T. Bergmann, Barry A. Schechter, Jodi Luchs, Abayomi Ogundele
Clinical Ophthalmology. 2021-01-12 - 5 citationsLate-onset fungal interface keratitis following endothelial keratoplasty with positive donor fungal culture.Kenneth A Beckman, Mark S. Milner, Parag A. Majmudar, Jodi Luchs
American Journal of Ophthalmology Case Reports. 2020-06-01
Press Mentions
- FDA OKs New Dry Eye TreatmentAugust 20th, 2018
- Sun Pharma Announces U.S. FDA Approval of CEQUA™ to Treat Dry Eye DiseaseAugust 16th, 2018
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: